NDC properties for "Pylera (bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule" (RxCUI 1294621)
About this data
The tables show NDC propoerties for Pylera (bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule with the RxCUI 1294621
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Pylera (bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule (RxCUI 1294621)
| MMSL_CODE | BD19736 |
|---|---|
| NDA | NDA050786 |
| RxCUI | 1294621 |
| SPL_SET_ID | 5cdacbf5-67be-42eb-bd54-8acc32ea1abc |
| SPL_SET_ID | 7fe5d2db-c59d-4e15-acd7-f9df8eca45aa |
| Prescribable Synonym | PYLERA 140 MG / 125 MG / 125 MG Oral Capsule |
| RXNAV_STR | Pylera (bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule |
| RxNorm Name | bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera] |
| RxNorm Synonym | Pylera (bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule |
| Tallman Synonym | bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG Oral Capsule [Pylera] |
| Tallman Synonym | Pylera (bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline hydrochloride 125 MG) Oral Capsule |
| Related queries | Interactions (for RxCUI 1294621) |
NDC Properties
NDC Item 58914060120
| NDC 9 | 58914-601 |
|---|---|
| NDC 10 | 58914-601-20 |
| NDC Item | 58914060120 |
| Packaging | 1 BLISTER PACK in 1 BOX (58914-601-20) / 120 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | white(Opaque white) |
| Color | C48325 __ |
| FDA SPL set id | 746906 |
| Imprint code | Aptalis;BMT |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-08-01 |
| Marketing status | ACTIVE |
| NDA | NDA050786 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 58914-601 |
NDC Item 61269038012
| NDC 9 | 61269-380 |
|---|---|
| NDC 10 | 61269-380-12 |
| NDC Item | 61269038012 |
| Packaging | 10 BLISTER PACK in 1 BOX (61269-380-12) / 12 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(opaque) |
| Color | C48325 __ |
| FDA SPL set id | 799010 |
| Imprint code | Aptalis;BMT |
| Labeler | H2-Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2023-10-01 |
| Marketing status | ACTIVE |
| NDA | NDA050786 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 61269-380 |
NDC Item 58914060120
| NDC 9 | 58914-601 |
|---|---|
| NDC 10 | 58914-601-20 |
| NDC Item | 58914060120 |
| Packaging | 1 BLISTER PACK in 1 BOX (58914-601-20) / 120 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | white(Opaque white) |
| Color | C48325 __ |
| FDA SPL set id | 746906 |
| Imprint code | Aptalis;BMT |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-08-01 |
| Marketing status | ACTIVE |
| NDA | NDA050786 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 58914-601 |
NDC Item 61269038012
| NDC 9 | 61269-380 |
|---|---|
| NDC 10 | 61269-380-12 |
| NDC Item | 61269038012 |
| Packaging | 10 BLISTER PACK in 1 BOX (61269-380-12) / 12 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(opaque) |
| Color | C48325 __ |
| FDA SPL set id | 799010 |
| Imprint code | Aptalis;BMT |
| Labeler | H2-Pharma, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2023-10-01 |
| Marketing status | ACTIVE |
| NDA | NDA050786 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 61269-380 |